BeStock  
Stocks › Biotechnology › ANAB

AnaptysBio ANAB

US equityMarket cap rank #2932Biotechnology
$46.63 −$0.77 (-1.62%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $46.63 0.00%
Open$47.49
Prev close$47.40
Day range$46.05 – $47.71
Volume432.5K
Market cap$1.39B
P/E (TTM)9.0
Dividend yield–

Fundamentals

Latest reported quarter: Q1, ended Sep 2026

Revenue$30.27M+18.5% YoY
Operating profit$19.91M+157.5% YoY
Net profit$3.88M+107.3% YoY
Diluted EPS$0.11+106.0% YoY
Free cash flow-$9.54M+63.2% YoY
Operating cash flow-$9.54M

Revenue, last 8 quarters

$30.0MSep '24$43.1MDec '24$27.8MMar '25$22.3MJun '25$76.3MSep '25$108.2MDec '25$25.6MMar '26$30.3MSep '26

Net profit, last 8 quarters

$-32.9MSep '24$-21.8MDec '24$-39.3MMar '25$-38.6MJun '25$15.1MSep '25$49.6MDec '25$-52.9MMar '26$3.9MSep '26

Diluted EPS by quarter

-1.14Sep '24-0.72Dec '24-1.28Mar '25-1.34Jun '250.52Sep '251.58Dec '25-1.84Mar '260.11Sep '26

Free cash flow by quarter

$-10.1MSep '24$-66.6MDec '24$-10.7MMar '25$-40.3MJun '25$-27.4MSep '25$98.1MDec '25$-25.9MMar '26$-9.5MSep '26

Annual revenue

$63.2MFY21$10.3MFY22$17.2MFY23$91.3MFY24$234.6MFY25$53.0MFY26

Profitability & balance sheet

Operating margin65.7%
Net margin12.8%
Current ratio8.40
Liabilities / assets93.2%
Cash & investments$152.99M
Total debt$10.36M
Net cash (debt)$142.63M

Income statement

Line item 2027 Q1 2026 ANNUAL 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $30.27M $53.04M $25.56M $234.60M $108.25M
Total Operating Revenue $30.27M $53.04M $25.56M $234.60M $108.25M
Operating Expense $10.37M $20.72M $60.19M $7.70M -$137.66M
Selling and Admin Expenses $11.64M $23.39M $26.20M $11.35M -$23.60M
-General & Admin Expense $11.64M $23.39M $26.20M $11.35M -$23.60M
Research & Development -$1.27M -$2.67M $33.99M -$3.64M -$114.06M
Operating Profit $19.91M $32.32M -$34.64M $226.90M $245.91M
Net Non-Operating Interest Income (Expense) -$17.30M -$37.94M -$18.21M -$70.08M -$20.89M
Non-Operating Interest Income $1.44M $3.25M $2.65M $9.81M -$1.18M
Non-Operating Interest Expense $18.74M $41.19M $20.86M $79.89M $19.71M
Other Income (Expense) $667,000.00 $525,000.00 -$1,000.00 $5.45M $20,000.00
Other Non-Operating Income (Expenses) $667,000.00 $525,000.00 -$1,000.00 $5.45M $20,000.00
Pretax Profit $3.27M -$5.09M -$52.84M $162.28M $225.04M
Tax -$608,000.00 -$181.45M $40,000.00 $772,000.00 $689,000.00
Net Profit $3.88M $131.00M -$52.88M -$13.23M $49.61M
Profit from Continuing Operations $3.88M $176.36M -$52.88M $161.50M $224.35M
Net Income from Discontinuous Operations $0.00 -$45.36M – -$174.74M –
Net Income to Parent Company $3.88M $131.00M -$52.88M -$13.23M $49.61M
Net Income to Common Stockholders $3.88M $131.00M -$52.88M -$13.23M $49.61M
Basic EPS $0.13 $4.52 -$1.84 -$0.46 $1.79
Diluted EPS $0.11 $3.50 -$1.84 -$0.46 $1.58

Balance sheet

Line item 2027 Q1 2026 ANNUAL 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $307.04M $316.98M $329.68M $364.40M $364.40M
Total Current Assets $188.37M $198.43M $316.11M $350.25M $350.25M
Cash and Cash Equivalents & Short-Term Investments $152.99M $164.14M $286.46M $211.64M $211.64M
-Cash and Cash Equivalents $135.39M $133.83M $248.47M $138.20M $138.20M
-Short Term Investments $17.60M $30.32M $37.99M $73.44M $73.44M
Receivables $34.00M $25.63M $25.75M $33.85M $33.85M
-Accounts Receivable $30.49M $25.63M $25.75M $33.85M $33.85M
-Taxes Receivable $3.28M – – – –
-Other Receivables $220,000.00 – – – –
Prepaid Assets $1.38M – – – –
Total Non-Current Assets $118.67M $118.56M $13.58M $14.15M $14.15M
Net PPE $11.17M $11.66M $13.32M $12.63M $12.63M
-Gross PPE $11.27M $11.76M $20.59M $12.72M $12.72M
-Accumulated Depreciation -$106,000.00 -$101,000.00 -$7.27M -$92,000.00 -$92,000.00
Non-Current Deferred Assets $107.25M $106.64M – $0.00 $0.00
Other Non-Current Assets $256,000.00 $256,000.00 $256,000.00 $1.52M $1.52M
Total Liabilities $286.22M $306.40M $316.94M $327.19M $327.19M
Total Current Liabilities $22.42M $35.35M $41.70M $38.63M $38.63M
Payables $879,000.00 $4.39M $7.52M $3.87M $3.87M
-Accounts Payable $879,000.00 $4.39M $7.52M $3.87M $3.87M
Current Accrued Expenses $14.95M $22.93M $26.53M $21.58M $21.58M
Short-Term Debt and Capital Lease Obligation $2.20M $2.16M $2.12M $2.08M $2.08M
-Current Capital Lease Obligation $2.20M $2.16M $2.12M $2.08M $2.08M
Total Non-Current Liabilities $263.80M $271.05M $275.24M $288.56M $288.56M
Long Term Accounts Payable and Other Payables $3.62M $3.62M – $0.00 $0.00
Long Term Debt and Capital Lease Obligation $10.36M $10.93M $11.49M $12.03M $12.03M
-Long Term Capital Lease Obligation $10.36M $10.93M $11.49M $12.03M $12.03M
Other Non-Current Liabilities $249.82M $256.49M $263.74M $276.53M $276.53M
Total Equity $20.82M $10.59M $12.75M $37.21M $37.21M
Stockholders' Equity $20.82M $10.59M $12.75M $37.21M $37.21M
Capital Stock $30,000.00 $30,000.00 $29,000.00 $28,000.00 $28,000.00
-Common Stock $30,000.00 $30,000.00 $29,000.00 $28,000.00 $28,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $658.66M $652.27M $838.31M $809.77M $809.77M
Retained Earnings -$637.69M -$641.56M -$825.44M -$772.56M -$772.56M
Gains/Losses Not Affecting Retained Earnings -$181,000.00 -$151,000.00 -$146,000.00 -$24,000.00 -$24,000.00
Other Current Assets – $8.65M $3.91M – –
Investments and Advances – $0.00 – $0.00 $0.00

Cash flow

Line item 2027 Q1 2026 ANNUAL 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$9.54M -$52.56M -$25.92M $19.70M $98.00M
Net cash flow from continuing operations -$9.54M -$1.40M -$25.92M $161.79M $240.09M
Net Income from Continuing Operations $3.88M $176.36M -$52.88M $161.50M $224.35M
Gain/Loss from Continuing Operations $18.74M $41.19M – $79.89M –
Depreciation & Depletion & Amortization $495,000.00 $968,000.00 $610,000.00 $1.88M $67,000.00
Deferred Tax -$608,000.00 -$183.70M – $0.00 –
Change in Working Capital -$35.17M -$44.57M -$8.71M -$80.53M $20.10M
-Change in Receivables -$4.86M $4.97M $8.10M $6.92M $41.84M
-Change in Prepaid Assets $2.69M -$3.67M $1.50M $1.81M $1.17M
-Change in Payables and Accrued Expense -$32.47M -$44.85M -$17.82M -$87.33M -$22.42M
-Change in Other Current Liabilities -$528,000.00 -$1.02M -$499,000.00 -$1.93M -$494,000.00
Cash Flow from Discontinued Operating Activities $0.00 -$51.16M – -$142.09M –
Net cash flow from investing $12.59M $42.55M $34.98M $228.03M $73.50M
Net Cash Flow from Continuing Investing Activities $12.59M $42.55M $34.98M $228.12M $73.59M
Net Investment Purchase and Sale $12.59M $42.55M $35.00M $228.12M $73.50M
Financing Cash Flow -$1.48M -$94.36M $1.21M -$132.61M -$43.13M
Net Cash Flow from Continuing Financing Activities -$1.48M $5.64M $1.21M -$132.61M -$43.13M
Net Common Stock Issuance $4.44M $25.37M $14.02M -$54.37M $8.83M
Net Other Financing Charges -$5.92M -$19.73M -$12.81M -$76.80M -$51.96M
Ending Cash Balance $135.39M $133.83M $248.47M $138.20M $138.20M
Net Change in Cash $1.57M -$104.37M $10.27M $115.12M $128.36M
Beginning Cash Balance $133.83M $238.20M $238.20M $23.08M $109.83M
Free Cash Flow -$9.54M -$52.56M -$25.94M $19.70M $98.08M
Proceeds from Stock Option Exercised – $0.00 $0.00 -$1.45M $0.00
Cash Flow from Discontinued Financing Activities – -$100.00M – $0.00 –
Other Non-Cash Items – – $20.86M – –
Net PPE Purchase and Sale – – -$17,000.00 – –

Discussion

No comments yet — be the first to weigh in on ANAB.

Sign in to join the discussion.

Scroll to Top